14th October 2026, Wednesday

TechPharus

Latest Posts

HealthTech News

  • Most patients won’t endorse AI medical responses without a clinician’s review, study finds
    on October 14, 2026 at 9:30 pm

    In a Columbia University School of Nursing study surveying 1,185 U.S.-based adults about AI use in secure medical portals, 63% of patients said they would not endorse AI-generated medical responses without a clinician’s review. This suggests that while patients see value in using AI for certain health care tasks, they prefer a human review when medical advice is involved. The study, “Public Perceptions of Timeliness for AI Use and Human Oversight,” was published in the JAMA Network Open on Oct. 14, 2026.

  • Cancer-promoting protein also helps engineered immune cells fight tumors in lab tests
    on October 14, 2026 at 9:20 pm

    Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren’t treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.

  • Herpes ‘remedies’ sold on Amazon and Walmart pose public health risk, FDA warns
    on October 14, 2026 at 9:20 pm

    Creams, sprays and washes that promise relief from genital herpes are easy to order online, but none of them has been approved to treat the infection.

  • Neighborhood conditions linked to childhood cancer survivors’ long-term health
    on October 14, 2026 at 9:10 pm

    Survivors of childhood cancer can make lifestyle changes to reduce later-in-life chronic health conditions, such as diabetes and heart disease. Still, some survivors report local environmental barriers to taking these actions. According to a new study from St. Jude Children’s Research Hospital scientists, survivors from the most vulnerable neighborhoods—those with features including low income per capita, poor walkability, a lack of access to nearby health care or fewer healthy food options—have a significantly elevated risk. The findings, published recently in eClinicalMedicine, identify a need to consider these community-level factors to better support survivors.

  • Phenobarbital shows no clear advantage over diazepam for alcohol withdrawal, large study finds
    on October 14, 2026 at 9:00 pm

    Alcohol withdrawal is a common and dangerous medical emergency. Although benzodiazepines remain the standard treatment for this condition, the use of the barbiturate phenobarbital has increased by more than 200% in the last decade with limited evidence to suggest that this practice is safe and effective.